AzTrials
AzTrials

Critical IllnessSERA-EffortNCT07109570

Surface Electrical Myography, Oxygen Consumption, Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit

An observational study of Critical Illness and Intensive Care Units (ICUs), run by Leiden University Medical Center at 1 site in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to measure effort using esophageal pressure measurements, oxygen consumption and diaphragm activity in mechanically ventilated Intensive Care Unit patients during a Spontaneous Breathing Trial. Read more about this study

Who is it for?
Ages 18 years and older
How many people
60 participants
Where
1 siteNetherlands
Study dates
8 Jul 2025to Jun 2029
How long will I take part?
2 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The intended population consists of adults who are mechanically ventilated in the ICU and meet the criteria for a regular spontaneous breathing trial according to the ruling LUMC protocol.

Who may be able to join

  • 18 years of age or older
  • Esophageal catheter in situ (standard of care)
  • Eligible for an SBT in the near future according to the LUMC SBT protocol currently valid

Who cannot join

  • Severe cardiac failure NYHA class IV without mechanical support (LVAD or Impella)
  • COPD Gold IV
  • Pregnancy
  • Patients with ECMO

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Abraham Schoe, MD, PhD contact

+31715265018

a.schoe@lumc.nl

Florence E Smits, MSc contact

f.e.smits@lumc.nl

Netherlands1 site, 1 recruiting
  • Leiden University Medical Centre

    Leiden, 2300 ZA

    Abraham Schoe, MD, PhD, 0681174475, a.schoe@lumc.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Surface Electrical Myography, Oxygen Consumption (VO2), Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit (ICU): SERA-Effort Study

The goal of this observational study is to measure effort using esophageal pressure measurements, oxygen consumption and diaphragm activity in mechanically ventilated Intensive Care Unit patients during a Spontaneous Breathing Trial. The main question aims to answer whether the sEMG signal derived from the SERA device, effort parameters and oxygen consumption have an association with weaning failure.

Participants will be measured while performing a spontaneous breathing trial.

Read the detailed description

Rationale: In patients mechanically ventilated for more than 72 hours weaning from the ventilator and successful extubation can be problematic. The spontaneous breathing trial (SBT) is a tool to predict successful extubation. However re-intubation withing 48 hours occurs in 15-20% of the patients after a successful SBT. The key parameter of the SBT is the rapid shallow breathing index (RSBI). Since the rate of extubation failure is still high the search for a better parameter than the RSBI is warranted.

Recently measurement of the surface electromyography of the respiratory muscles has become available with the Surface Electromyography Respiratory Assist (SERA), which has been developed by Demcon-Macawi. The device is currently investigated in neonates in search of an apnea detection algorithm (protocol ID NL83937.000.23). The device gives an estimate of the magnitude of the electric activity of the diaphragm which has a good correlation with the force the diaphragm generates. It is known that the diaphragm is the key respiratory muscle and that dysfunction of the diaphragm has a strong association with weaning failure. We think that this signal could be of great value in detecting weaning and extubation failure therefore we want to investigate if the sEMG signal derived from the SERA device has an association with weaning failure, defined as an unsuccessful SBT, or extubation failure, defined as the need for re-intubation for respiratory reasons within 48 hours after a successful SBT and subsequent extubation.

Objective: Primary objective is to investigate if the sEMG signal derived from the SERA device has an association with weaning failure, defined as an unsuccessful SBT, or extubation failure, defined as the need for re-intubation for respiratory reasons within 48 hours after a successful SBT and subsequent extubation.

Secondary objectives are to investigate if the sEMG signal has an association with other measurements of effort (pressure time product (PTP), Work of breathing (WOB), Transpulmonary pressure swings, oesophageal pressure swings, and oxygen consumption).

Study design: A single center prospective cohort feasibility/pilot study performed on patients undergoing a spontaneous breathing trial. Measurements will commence 10 minutes before the planned SBT, will continue during the SBT until 10 minutes after the termination of the SBT. Measurement data will be derived from the SERA, the mechanical ventilator (Hamilton C6), and the Masimo ISA OR+. The SBT will done according to the ruling protocol in the LUMC.

Intervention: None Main study parameters/endpoints: Magnitude of the electric signal (base level, or tonic level, maximum level, AUC of the electric signal during contraction in inspiration and expiration, differences between maximum and tonic levels), VO2, PTP, WOB, RSBI, diaphragmatic pressure swing.

Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: The collection of data will not affect the standard of care. Therefore, the patient's risk is negligible and the burden is minimal.

Medical subject headings
Critical Illness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Extubation failure

    Extubation failure is defined by the need for reintubation or death.

    Measured: 48 hours after extubation

  2. sEMG differences during SBT

    The AUC of the voltage signal, the phasic level (difference between tonic level and maximum level) and the tonic level (base level).

    Measured: 10 minutes before switch from support to no support ventilation, the whole duration of the SBT, and the 10 minutes after the SBT when there is again support.

Secondary outcomes (5)
  1. Differences of oxygen consumption during SBT

    The values of oxygen consumption (in milliliter/minute) and the differences between start, during, and end of the SBT.

    Measured: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  2. Differences of esophageal pressure swings measured with an esophageal catheter during SBT

    The values of pressure swings (in cmH2O), measured with an esophageal catheter, and the differences between start, during, and end of the SBT.

    Measured: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  3. Differences of work of breathing measured with an esophageal catheter during SBT

    The values of work of breathing (in Joules/liter), measured with an esophageal catheter, and the differences between start, during, and end of the SBT.

    Measured: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  4. Differences of pressure-time product measured with an esophageal catheter during SBT

    The values of pressure-time product (in cmH2O/seconds), measured with an esophageal catheter, and the differences between start, during, and end of the SBT.

    Measured: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  5. Differences of rapid shallow breathing index during SBT

    The values of rapid shallow breathing index (breaths/minute/liter) and the differences between start, during, and end of the SBT.

    Measured: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2025
  2. Study start8 Jul 2025
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completionJun 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
Target duration
2 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07109570
Sponsor's protocol ID
P24.116
Other IDs
NL86876.058.24
Acronym
SERA-Effort
Status last verified
Nov 2025
First submitted
31 Jul 2025
Last updated
26 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness and Intensive Care Units (ICUs), run by Leiden University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Abraham Schoe, MD, PhD (+31715265018, a.schoe@lumc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Extubation failure (time frame: 48 hours after extubation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in